Share

Ozempic’s Effect on Food Innovation

Mattson’s survey of anti-obesity medication patients showcases the potential disruption these new weight-loss drugs may have on the food industry and what consumers will be looking for in their foods and beverages.
injectable weight-loss medication
Dale Buss Dale Buss

Food Technology Magazine

Anti-obesity drugs have dropped on the food business in the last year like ChatGPT has dropped on the world. And according to experts assembled for a recent Mattson webinar on the topic, the effects of new appetite suppressants including Ozempic, Wegovy, and Zepbound have only begun to be felt among American consumers and the food industry that sells to them.

The blockbuster new anti-obesity medications have attracted millions of consumers already, registered significant weight losses for most of them, improved the overall health of many of them, and begun to bend the long-term arc of wellness in unprecedented ways. But …

Login or Sign Up To Continue

You’ve hit your limit of free articles. Either sign in to your existing account, or sign up to be an IFT member and get access to hundreds of digital resources and articlers.

Login Become a Member

Hero Image: © aprott/iStock/Getty Images Plus

Authors

  • Dale Buss

    Dale Buss Writer

    Dale Buss is an award-winning journalist and book author whose career has included reporting for The Wall Street Journal, where he was nominated for a Pulitzer Prize (daledbuss@aol.com).

Categories

  • Food Business Trends

  • Food Health Nutrition

  • Consumer and Marketplace Trends

  • Food Product Development

  • New Product Development

  • Obesity and Weight Management

  • Food Technology Magazine